Nintedanib has anti-fibrotic and anti-inflammatory activity and is approved for the treatment of idiopathic pulmonary fibrosis. The aim of this study was to noninvasively assess the efficacy of nintedanib in a mouse model of partial lung irradiation to prevent radiation-induced lung damage (RILD).
http://ift.tt/2hj5AQ8
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου